The following post was originally issued to The Lyons Share members on October 30, 2018. Former market leaders tech and biotech (among others) are…

The following post was originally issued to The Lyons Share members on October 30, 2018. Former market leaders tech and biotech (among others) are…
The following post was originally issued to TLS Premium Members on June 12. A popular biotech ETF is testing potentially formidable resistance on its chart.…
The bruised and bloodied Biotech sector is testing a trendline that may determine whether it has one more bull bounce – or if its bubble…
A key index of biotechnology stocks may be approaching significant levels of resistance. Throughout the course of the post-February rally, one topic that has been…
If there must be a poster child for the 6-year cyclical bull market, it is likely the biotech sector. At least that is certainly true…
While the post-2009 cyclical bull market has yet to run its course, there is a clear leader in the clubhouse in the race for poster…
Biotech Sector: Support Levels To Watch No sector has exemplified these past few years of the cyclical bull market as much as biotechnology stocks. Likewise,…
There is a fervent debate in some financial circles regarding the existence – or non-existence – of a biotech bubble. It is a challenging, and…